Astec Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 19.61 Cr
as on 21-06-2024
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.20 Cr
as on 21-06-2024
- Satisfied Charges ₹ 437.74 Cr
as on 21-06-2024
- Revenue -6.67%
(FY 2023)
- Profit -71.59%
(FY 2023)
- Ebitda -50.50%
(FY 2023)
- Net Worth 5.76%
(FY 2023)
- Total Assets 9.16%
(FY 2023)
About Astec Lifesciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 533138 and on the National Stock Exchange(NSE) under ASTEC.
The Corporate was formerly known as Urshila Traders Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 19.61 Cr.
The company currently has active open charges totaling ₹30.20 Cr. The company has closed loans amounting to ₹437.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Astec Lifesciences Limited India are Anurag Roy as Ceo, Tejashree Pradhan as Company Secretary, and Krishnamurthy Suryanarayan as Cfo. Nadir Godrej, Anjali Gupte, Balram Yadav, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Astec Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Roy | CEO | 28-Jul-2021 | Current |
| Tejashree Pradhan | Company Secretary | 01-Nov-2018 | Current |
| Krishnamurthy Suryanarayan | CFO | 03-May-2023 | Current |
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkumar Dhekne  | Director | 18-Dec-2020 | Current |
| Nadir Godrej | Director | 12-Oct-2015 | Current |
| Govindan Rishinaradamangalam | Director | 30-Jan-2020 | Current |
| Brahma Vyas | Director | 29-Jan-2016 | Current |
| Balram Yadav | Director | 12-Oct-2015 | Current |
| Anjali Gupte | Director | 18-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Astec Lifesciences.
Astec Lifesciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.67% decrease. The company also saw a substantial fall in profitability, with a 71.59% decrease in profit. The company's net worth moved up by a moderate rise of 5.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astec Lifesciences?
In 2023, Astec Lifesciences had a promoter holding of 66.76% and a public holding of 33.23%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
John Cockerill India LimitedActive 38 years 6 monthsAnjali Gupte and Nandkumar Dhekne are mutual person
Creamline Dairy Products Ltd.Active 38 years 1 monthNadir Godrej and Balram Yadav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 18 Jul 2013 | ₹22.00 Cr | Open |
Idbi Bank Limited Creation Date: 10 Jan 2011 | ₹5.20 Cr | Open |
Idbi Bank Limited Creation Date: 30 Jun 2009 | ₹3.00 Cr | Open |
How Many Employees Work at Astec Lifesciences?
Astec Lifesciences has a workforce of 615 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astec Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astec Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
